Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|September 7, 2002
Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in miceAlexander L Kovalchuk, Siegfried Janz
Oncotarget|June 8, 2018
Transcriptional activation of p21Waf1 contributes to suppression of HR by p53 in response to replication arrest induced by camptothecinLarisa Y Romanova, Frederick Mushinski, Alexander L Kovalchuk
Oncogene|May 14, 2003
E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cellsAlexander L Kovalchuk, Joong Su Kim, Siegfried Janz
Immunology|March 24, 2009
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytesRafael Casellas, Arito Yamane, Alexander L Kovalchuk, et al.
Cancer Research|December 26, 2003
BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocationsSantiago Silva, Alexander L Kovalchuk, Joong Su Kim, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 26, 2007
Differential cutaneous wound healing in thermally injured MRL/MPJ miceThomas A Davis, Mihret Amare, Shruti Naik, et al.
Immunologic Research|July 30, 2008
Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartmentsChen-Feng Qi, Zhaoyang Li, Mark Raffeld, et al.
The American Journal of Pathology|July 21, 2017
Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic AutoantibodyShweta Jain, Jerrold M Ward, Dong-Mi Shin, et al.
Vaccines|February 28, 2023
A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal ModelsVladimir A Ledov, Marina E Golovina, Biana I Alkhazova, et al.
Vaccines|April 23, 2025
A Candidate Ac3-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical TrialVladimir A Ledov, Victor V Romanenko, Marina E Golovina, et al.
Pageof 4